Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Web3’s biggest investors back social-fi innovation company /Reach in a bid to ‘fix Crypto Twitter’




Seedphrase, Pranksy, Gmoney, Zeneca and more have invested in a new protocol built to bring quality engagement and beat the Twitter bots

NEW YORK, Dec. 15, 2023 /PRNewswire/ — A group of the world’s best known cryptocurrency and NFT investors are financially backing a new social-fi innovation company to ‘fix Crypto Twitter’. The company, ‘/Reach’, has attracted seed funding from a wide number of public facing figures including Seedphrase, Zeneca, Pranksy, Gmoney, Dingaling, and Mooncat2878. Previous institutional funding from amongst this group include investments in Blur, LooksRare, SuperRare, and NFTNow.

L’anamour and 8an, co-founders of /Reach shared: “Twitter is the home of the international crypto community, yet the platform, the algorithm, and the millions of fake profiles are a constant source of frustration to people and businesses alike. We’re here to change this, and we’ve built a fit-for-pupose protocol and gathered together some of the biggest names in crypto to help us achieve this mission.”

After completion of a beta phase involving onboarding over 6,000 users, /Reach is planning its full launch for 14:00 EST Monday 18th December powered by the $REACH token.

The new company and its investors are looking to use social-fi innovation to fix some of the social media platform’s most glaring problems. The protocol’s USP which allows it to do this is a unique integration between Discord, the home of closed crypto communities, and Twitter/X. This enables anyone to promote their content to an engaged, audited user base while remunerating them for their contribution to the network effects.

This integration allows users and businesses alike to break through the Twitter algorithm and promote their content to targeted audiences. The protocol has already garnered interest from large gaming and media incumbents outside of web3 as a planned next step for growth.

Despite its position as the unofficial “home” of the crypto industry online, Twitter/X has increasingly come under fire from inside and outside of the blockchain industry for the prevalence of bots, fake followers, and low quality engagement across the platform.

A study earlier this year found that many of the biggest crypto profiles have 100,000s of fake ‘bot’ followers inflating their communities. These same fake profiles are also used to promote projects with artificial and low quality engagement on social posts. Elon Musk’s attempts to prevent this since he acquired the company have had limited results, Twitter/X is predicted to lose 30 million users over the next two years – almost 10% of its active user base.

Seedphrase, one of the most recognisable names on Crypto Twitter, the owner of the rarest Cryptopunks, and lead advisor of /Reach shared:

“I’m happy to announce that I’ve joined Get Reach as an advisor and investor in a bid to fix crypto Twitter and help the platform become what it was meant to be. The average organic engagement rate on X is only currently 0.05%. There is high demand for tools to help grow user engagement, while being safeguarded from unpredictable algorithmic changes and competition.

Get Reach’s platform fosters a collaborative environment where creators and contributors unite to enhance the visibility of Web3 projects, while reaping rewards for their participation. The onus is on us to welcome corporates into web3, and I see Get Reach as the perfect gateway for this with a true decentralised ethos.”

/Reach’s full launch will take place at 14:00 EST on Monday 18th December with full details to be released on the project’s Twitter/X page on Monday.


/Reach is a simplified, automated, permissionless protocol for quality engagement rewarding, powered by $REACH. The /Reach protocol allows for brands, projects, communities, and individuals to leverage the network effects of a large, vetted and audited audience to organically amplify their key pieces of content, and reward them for it. 100% of all rewards put up by creators are redistributed back into the network.

/Reach was founded by 8an, former venture developer at Rocket Internet, founding team at Numan, and co-founder of art fractionalisation protocol Particle,  and Lanamour, former private equity investor and founder of vintage photography platform FocusBloc. /Reach raised $1,000,000 on chain in less than 24 hours from the likes of Seedphrase, Zeneca, Pranksy, Gmoney, Dingaling, Canary Labs, NxGen, PunkDAO, Mooncat2878, Dingaling, and 0xSun and others who have been using the /Reach protocol throughout its beta phase and have seen the impact it can have on their communication strategies.


Having been involved in the crypto space since 2013, Seedphrase (Daniel Maegaard) is one of the most prolific figures in the web3 space and is highly involved in luxury fashion, music and generative art. He has amassed one of the largest personal collections of digital art and NFTs which includes the only 1/1 Cryptopunk#8348.


Known as one of the educational pillars of web3, Zeneca (Roy Bhasin) has helped the masses with onboarding to the world of NFTs by way of his Twitter/X posts and founding of the ZenAcademy and 333Club. Despite a more recent entrance to digital collectibles, Zeneca’s focus on value creation and ability to simplify complex topics has cemented him as a crypto thought leader.


Boasting almost 500,000 followers on Twitter/X, Pranksy is known to many as the apex of NFT collecting and trading, having sold over 1,250 Bored Apes and earning over 1,000ETH trading CryptoPunks.


A founder and collector, GMONEY is one web3’s most notable pioneers. Known simply by his alias and recognized immediately by the rare ape CryptoPunk that he uses as his PFP, GMONEY is the founder of Admit One (a membership-based group of NFT collectors) and 9DCC (a web3-based fashion brand).


PunkDao are the the largest decentralized organization holding punks. They invest in projects through Punk Ventures, a VC investment DAO with membership on application. 


View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading

Latest news